Aandeel A217330 CYTOGEN, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Cytogen, Inc.

Aandelen

A217330

KR7217330000

slotkoers Korea S.E.
Andere beurzen
 00:00:00 08-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
11.390 KRW -1,81% Intraday-grafiek van Cytogen, Inc. -1,73% -15,75%
2023 Cytogen, Inc. Rapporteert winstresultaten voor het volledige jaar eindigend op 31 december 2022 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Cytogen, Inc. announced that it has received KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors
Cytogen, Inc. announced that it expects to receive KRW 9.8 billion in funding from NH Investment & Securities Co., Ltd., Samsung Securities Co., Ltd. and other investors
Cytogen, Inc. announced that it has received KRW 55.49999 billion in funding from CanDx Holdings Limited
Cytogen, Inc. announced that it expects to receive KRW 99.999821616 billion in funding from Candx Holdings Limited
Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. from Jeon Byung Hee and others for KRW 110 billion
Cytogen, Inc. announces tranche update
Cytogen Raising KRW10 Billion to Finance Operations
Cytogen, Inc. announced that it expects to receive KRW 69.99999 billion in funding from Excelsior Capital Korea Limited
Cytogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Cytogen, Inc.(KOSDAQ:A217330) added to S&P Global BMI Index
TSD Life Sciences Co.,Ltd. announced that it has received KRW 2.9999853 billion in funding from Cytogen, Inc.
TSD Life Sciences Co.,Ltd. announced that it has received KRW 2.9999853 billion in funding from Cytogen, Inc.
Cytogen, Inc. announced that it has received KRW 30 billion in funding
Cytogen, Inc. announced that it expects to receive KRW 30 billion in funding
TSD Life Sciences Co.,Ltd. announced that it expects to receive KRW 2.9999853 billion in funding from Cytogen, Inc.
Cytogen, Inc. announced that it has received KRW 10 billion in funding
Cytogen, Inc. announced that it expects to receive KRW 10 billion in funding
Well Marker Bio Co., Ltd. announced that it has received KRW 18 billion in funding from a group of investors
Cytogen, Inc. has completed an IPO in the amount of KRW 20.4 billion.
Cytogen, Inc. has filed an IPO.
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers A217330
  4. Nieuws Cytogen, Inc.
  5. Andere talen